Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)
Clinical trial NCT03482713 · COMPLETED
Trial details
- NCT number
- NCT03482713
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2018-06-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.